ReviewCancer drug resistance (Alhambra, Calif.)2019
Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma.
Cathy W Levenson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it